Delivery Order SPE2DB24D8002-SPE2DB24FJMWW

Award Date 9/6/24
Potential Completion Date 9/9/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business that specializes in providing pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government. The $1,261.34 contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, which are used to treat diabetes. This award is associated with Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,487.31 contract is for the delivery of Trulicity 1.5 mg/0.5 mL pens, a medication used to treat diabetes. The award is issued under Dakota Drug's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,579.40, is for the delivery of Trulicity 1.5 mg/0.5 ml pens. This contract is not associated with a set-aside program. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of Trulicity 3 mg/0.5 ml pens. The contract has a ceiling value of $1,633.25 and a performance period ending on May 1, 2023. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a prescription medication used to treat diabetes. The contract has a total ceiling value of $3,656.14 and a performance period extending through May 5, 2023. Dakota Drug, Inc. is a key supplier to the DLA, holding a significant...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the supply of Trulicity 3 mg/0.5 ml pen 0.5 ml, a diabetes management product, to support U.S. Armed Forces medical operations. The contract has a ceiling value of $1,312.08 and a period of performance through May 30, 2025. Dakota Drug, Inc. holds a significant single-award...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $1,312.08 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) worth $999,999,999.00 with the DLA Troop Support Medical under the ECAT Generation V Program, which allows the company to provide a wide range of pharmaceutical products,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit Subchapter S corporation. The contract, valued at $2,882.20, is for the delivery of Trulicity 1.5 mg/0.5 ml pens. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00, which allows Dakota Drug, Inc. to provide a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $3,816.82, is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication used to treat diabetes. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Dakota Drug, Inc. holds with the DLA...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $1,312.08, is a firm fixed-price delivery order for the procurement of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product used to treat diabetes. This award is part of a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA Troop Support...
  • SPE2DB24D8002
    Indefinite Delivery Contract
  • SPE2DB24D8002-SPE2DB24FJMWW
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $1,906.50, is for the supply of 4.5 mg/0.5 ml Trulicity pens, a medication used to treat diabetes.

The award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc., valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations under the DLA Troop Support Medical's ECAT Generation V Program. This program seeks to procure commercial medical equipment, accessories, consumables, and medical simulation equipment from manufacturers and distributors. The current delivery order has a performance period through September 9, 2024 and does not have a set-aside designation.

Generated 12/6/24, 9:21 AM